首页> 外国专利> EFFECTIVE PART OF GINSENG, PREPARING METHOD AND USE THEREOF

EFFECTIVE PART OF GINSENG, PREPARING METHOD AND USE THEREOF

机译:人参有效部位,制备方法及其用途

摘要

An effective part of ginseng, preparing method and use thereof, wherein the method for preparing the effective part comprises the following steps: (1) cutting ginseng into pieces, extracting with aqueous ethanol or water solution containing ethanol, concentrating the extract until relative density is 0.8-1.3 at 80℃, obtaining solution A; (2) precipitating solution A with alcohol or water, concentrating supernatant until the ratio of concentrated solution to raw medicinal material is 1:0.25-2.5, obtaining solution B; (3) adding sodium hydroxide (NaOH) into solution B until concentration of NaOH is 0.1-2 mol/L, stirring, staying for 0.5-3 hours, centrifuging or filtering, obtaining solution C, putting solution C on weak polarity or non-polar macroporous resin column, sequentially washing the column with alkaline liquid, water and 5-45% ethanol, eluting with 45-80% ethanol, collecting the eluent to obtain solution D, recycling ethanol under reduced pressure, drying, dissolving the dried substance in 5-35% ethanol, centrifuging or filtering, obtaining solution E, putting solution E on weak polarity or non-polar macroporous resin column, washing the column with 10-50% ethanol, eluting with 50-80% ethanol, collecting the eluent to obtain solution F, recycling ethanol under reduced pressure, drying to obtain effective part of ginseng. The obtained effective part of ginseng contains the following ginsenoside components (pts. wt.): protopanaxadiol saponin Rd (3-43), protopanaxadiol saponin Rg6 (4-11), protopanaxadiol saponin F4 (6-17), panaxatriol saponin Rk3 (2-9), panaxatriol saponin Rh4 (5-16), panaxatriol saponin F2 (13-18), panaxatriol saponin Rg3 (0.5-4), panoxadiol saponin Rk1 (2-20), and panoxadiol saponin Rg5 (1-30). The above mentioned effective part of ginseng has effect in preventing leucocythemia and inhibiting solid tumor cell, and no distinct toxic side effect.
机译:人参有效部位及其制备方法和用途,其制备方法包括以下步骤:(1)将人参切成片,用乙醇水溶液或含乙醇的水溶液萃取,浓缩至相对密度为在80℃下为0.8-1.3,得到溶液A; (2)用酒精或水沉淀溶液A,浓缩上清液直至浓缩液与原料药的比例为1:0.25-2.5,得到溶液B; (3)在溶液B中加入氢氧化钠(NaOH),直到NaOH的浓度为0.1-2 mol / L,搅拌,静置0.5-3小时,离心或过滤,得到溶液C,将溶液C置于弱极性或非极性。极性大孔树脂柱,依次用碱性液体,水和5-45%的乙醇洗涤该柱,用45-80%的乙醇洗脱,收集洗脱液以获得溶液D,在减压下回收乙醇,干燥,将干燥的物质溶于5-35%乙醇,离心或过滤,得到溶液E,将溶液E放在弱极性或非极性大孔树脂柱上,用10-50%乙醇洗涤该柱,再用50-80%乙醇洗脱,收集洗脱液至获得溶液F,在减压下再循环乙醇,干燥以获得有效部分的人参。获得的人参有效成分包含以下人参皂苷成分(按重量计):原人参二醇二醇皂苷Rd(3-43),原人参二醇二醇皂苷Rg 6 (4-11),原人参二醇二醇皂苷F 4 (6-17),人参三醇皂苷Rk 3 (2-9),人参三醇皂苷Rh 4 (5-16),人参三醇皂苷F 2 (13-18),人参三醇皂苷Rg 3 (0.5-4),人参二醇二醇皂苷Rk 1 (2-20)和人参二醇二醇皂苷Rg 5 (1-30)。上述人参的有效部分具有预防白细胞增多症和抑制实体瘤细胞的作用,并且没有明显的毒性副作用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号